How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies.

Boyadzhieva, Zhivana; Ruffer, Nikolas; Kötter, Ina; Krusche, Martin

Boyadzhieva, Zhivana; Ruffer, Nikolas; Kötter, Ina; Krusche, Martin.

Afiliação

Boyadzhieva Z; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ruffer N; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kötter I; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Krusche M; Department of Rheumatology and Immunology, Klinikum Bad Bramstedt, Bad Bramstedt, Germany.

Rheumatology (Oxford) ; 62(11): 3518-3525, 2023 11 02.

Article em En | MEDLINE | ID: mdl-37233149

Assuntos

Síndrome de Bronquiolite Obliterante; Inibidores de Janus Quinases; Humanos; Masculino; Feminino; Algoritmos; Azacitidina; Bases de Dados Factuais; Mutação

Palavras-chave

VEXAS syndrome; autoinflammation; autoinflammatory disease; malignancy; myelodysplastic syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Janus Quinases / Síndrome de Bronquiolite Obliterante Tipo de estudo: Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google